Navigation Links
Genzyme to Build New R&D Center in Beijing
Date:4/22/2008

se patients in need. Approximately 125 patients are being treated in China through the Gaucher Initiative, Genzyme's humanitarian partnership with Project HOPE. Last year, the company began a collaboration with the Chinese firm Sunway Biotech Co. Ltd. with the goal of bringing a gene therapy for cardiovascular disease to patients in China and Genzyme is seeking to form additional partnerships with local companies.

Consistent with Genzyme's commitment to the environment and corporate responsibility, the new Beijing facility will feature an attractive architectural design and innovative green features that will create a healthy and comfortable workplace for employees, and reduce its environmental impact. The company intends to seek certification for the building with the U.S. Green Building Council's Leadership in Energy and Environmental Design (LEED) rating system. Genzyme's global corporate headquarters, Genzyme Center, achieved the highest LEED rating, and all of the company's facilities worldwide are being built to high environmental standards. Genzyme is conducting major R&D and manufacturing expansion projects in the United States, Belgium, France, the United Kingdom and the Netherlands, and is rapidly expanding its commercial operations in countries around the world.

Genzyme's new Beijing facility will be located in Zhongguancun (ZGC) Life Science Park, an area dedicated to academic and government research centers as well as pharmaceutical and biotechnology companies. The 200,000 square-foot building will be constructed with low-impact environmental techniques and methods, and will incorporate a range of environmentally responsible features, including: a living roof to reduce pollution caused by storm water runoff; a solar thermal system that will provide a significant portion of the building's hot water and reduce its energy consumption; and low-flow fixtures to limit water usage.

An all-glass exterior will provide employees with signific
'/>"/>

SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Genzyme Provides Update on Myozyme(R) Manufacturing
2. Genzyme Withdraws Bioenvisions European Filing of Evoltra(R) in Elderly AML Patients
3. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
4. Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration
5. Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
6. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
7. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
8. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
9. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
10. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
11. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... laureate Herbert Kroemer famously observed, referring to the ... where layers of different materials meet. In today,s ... of metal oxides are becoming increasingly prominent, with ... superconductors, ferroelectrics and multiferroics. Realizing the vast potential ...
(Date:1/15/2014)... IL (PRWEB) January 15, 2014 Look ... find hard-working items for the lab, from fluid handling ... Guaranteed-in-Stock (GIS)—ready to ship when you order. , ... Peristaltic Pumps , from the L/S® model for precise ...
(Date:1/15/2014)... Canada (PRWEB) January 15, 2014 This ... on nonclinical and clinical safety assessment in biosimilars. , ... path for biosimilar drug development, however the complex nature ... to quality, safety and efficacy extremely challenging. Based on ...
(Date:1/15/2014)... NY (PRWEB) January 15, 2014 The Microcompetition ... a major disease. One of these latent viruses is the ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic inflammatory ... theory, a study found that RA patients have high concentrations ...
Breaking Biology Technology:A deeper look at interfaces 2Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... Real-Time Location System provider for healthcare, is pleased to ... Real-Time Location System . The new messaging better captures ... – , Industry-Leading Accuracy , ... Applications Easy Installation and Maintenance ...
... been mysteriously falling for at least five years in the ... (CCD) is still largely unknown. In a report ... , researchers report that a widely used in-hive medication may ... and that this interaction may be at least partially responsible ...
... and SHENZHEN, China, Nov. 2, 2011 Advanced BioMedical ... internal fixation devices, is pleased to announce the formation ... comprised of three distinguished physicians and scientists. The combined ... critical scientific and strategic input as the Company continues ...
Cached Biology Technology:CenTrak, a Leading Real-Time Location System Provider, Unveils New Branding 2Advanced BioMedical Technologies Inc. Announces Formation of Scientific Advisory Board 2Advanced BioMedical Technologies Inc. Announces Formation of Scientific Advisory Board 3Advanced BioMedical Technologies Inc. Announces Formation of Scientific Advisory Board 4Advanced BioMedical Technologies Inc. Announces Formation of Scientific Advisory Board 5Advanced BioMedical Technologies Inc. Announces Formation of Scientific Advisory Board 6Advanced BioMedical Technologies Inc. Announces Formation of Scientific Advisory Board 7
(Date:4/24/2014)... recently introduced Clinical OMICs ... of OMICs technologies in clinical settings. These advanced ... transform medical care just as they revolutionized basic ... "GEN,s editors and reporters have written about the ... etc. for years," said John Sterling, editor-in-chief of ...
(Date:4/24/2014)... cheap way of making a high-powered lens that can ... Costing less than a cent, the lenses promise a ... remote areas. , The lens fabrication technique was invented ... (ANU) Research School of Engineering, who collaborated with Dr ... to find ways to transform the lentil-sized lens into ...
(Date:4/24/2014)... University of North Carolina at Chapel Hill have developed ... plaque that is at high risk of breaking off ... is the plaque that builds up in arteries as ... meaning that they are more likely to detach from ... , "Existing state-of-the-art technologies are capable of determining if ...
Breaking Biology News(10 mins):Droplet lens 2New ultrasound device may add in detecting risk for heart attack, stroke 2
... 2009 Landfilled waste decomposes in the absence ... methane. Landfills are classified as the second-largest human-made ... gas contains numerous non-methane hydrocarbons that are either ... biochemical reactions during waste degradation. Microbial methane ...
... tissues need continuous irrigation and drainage. Blood vessels feeding ... via the lymphatic system. While much is known about ... true for lymph vessels. Now though, Norrmn et al. ... drainage construction in the mouse embryo. The ...
... the composition and structure of a needlelike protein complex ... develop new strategies to thwart infection. The research, conducted ... National Laboratory, will be published April 26, 2009, in ... Molecular Biology . The scientists were studying a ...
Cached Biology News:Landfill cover soil methane oxidation underestimated 2Details of bacterial 'injection' system revealed 2
... antibiotic-based selection system for recombinant identification. Recombinant ... the need for costly color screening. This ... 100% accuracy in recombinant selection. pLivSelect is ... picking. This cloning kit can be used ...
Mouse monoclonal antibody raised against a partial recombinant PRG4. NCBI Entrez Gene ID = PRG4...
Mouse monoclonal antibody raised against a partial recombinant SCARB2. NCBI Entrez Gene ID = SCARB2...
...
Biology Products: